Jgp Global Gestao De Recursos Ltda. Bei Gene, Ltd. Transaction History
Jgp Global Gestao De Recursos Ltda.
- $43.9 Million
- Q4 2024
A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 9,374 shares of BGNE stock, worth $2.08 Million. This represents 3.94% of its overall portfolio holdings.
Number of Shares
9,374
Previous 9,375
0.01%
Holding current value
$2.08 Million
Previous $2.1 Million
17.73%
% of portfolio
3.94%
Previous 4.12%
Shares
22 transactions
Others Institutions Holding BGNE
# of Institutions
254Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.35 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.43 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.15 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$1.1 Billion0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$823 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...